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Reactive oxygen species (ROS) are produced during
normal metabolism and can function as signaling
molecules. However, ROS at elevated levels can
damage cells. Here, we identify the conserved target
of rapamycin complex 2 (TORC2)/Ypk1 signaling
module as an important regulator of ROS in the
model eukaryotic organism, S. cerevisiae. We show
that TORC2/Ypk1 suppresses ROS produced both
by mitochondria as well as by nonmitochondrial
sources, including changes in acidification of the
vacuole. Furthermore, we link vacuole-related ROS
to sphingolipids, essential components of cellular
membranes, whose synthesis is also controlled by
TORC2/Ypk1 signaling. In total, our data reveal that
TORC2/Ypk1 act within a homeostatic feedback
loop to maintain sphingolipid levels and that ROS
are a critical regulatory signal within this system.
Thus, ROS sensing and signaling by TORC2/Ypk1
play a central physiological role in sphingolipid
biosynthesis and in the maintenance of cell growth
and viability.
INTRODUCTION
Regulation of cell proliferation requires a balanced response to
both growth- and stress-related cues. The ability of cells to coor-
dinate this balance occurs, in part, through the evolutionarily
conserved target of rapamycin (TOR) kinase signaling network.
TOR functions as part of two distinct complexes, TOR com-
plexes 1 and 2 (TORC1 and TORC2), which phosphorylate and
modulate the activity of different members of the AGC family of
protein kinases. Thus, in mammalian cells, mTORC1 recognizes
S6K1, whereas mTORC2 recognizes AKT (also known as PKB)
as well as SGK (Hara et al., 2002; Sarbassov et al., 2005). This
specificity extends to budding yeast, where TORC1 recognizes
Sch9 and TORC2 recognizes Ypk1 and Ypk2 (Kamada et al.,
2005; Niles et al., 2012; Urban et al., 2007). Recognition of
Ypk1/2 by TORC2 also requires the activity of the PH-domainCcontaining proteins Slm1 and Slm2, which act by recruiting
Ypk1/2 to the plasmamembrane (PM), where TORC2 is localized
(Niles et al., 2012). TORC2 phosphorylation of Ypk1/2 enhances
their subsequent phosphorylation and activation by Pkh1/2, or-
thologs of mammalian PDK1 (Casamayor et al., 1999). Following
activation, Ypk1/2 carry out a number of functions to promote
cellular growth, including polarization of the actin cytoskeleton,
receptor-mediated endocytosis, and sphingolipid biosynthesis
(Loewith and Hall, 2011).
How TORC2 activity is modulated within cells remains poorly
understood; however, recent evidence suggests that complex
sphingolipids participate in this process (Berchtold et al., 2012).
Sphingolipids are essential structural components of eukaryotic
membranes, and, together with their biosynthetic precursors,
the sphingoid long chain bases (LCBs) and ceramides play
important roles in cell signaling, intracellular trafficking, and
response to stress. Previous studies have established TORC2/
Ypk1/2 signaling as a positive regulator of the early steps of
sphingolipid biosynthesis, including the first step carried out by
the enzyme serine palmityl transferase (SPT) as well as the sub-
sequent formation of ceramides (Aronova et al., 2008; Roelants
et al., 2011). Remarkably, inhibition of SPT activity with the drug
myriocin was observed to result in increased phosphorylation
of Ypk1 by TORC2 in a manner that requires changes in the PM
localization of Slm1/2. Specifically, Slm1 was shown to move
from PM-associated structures termed eisosomes to a domain
known as the membrane compartment containing TORC2
(MCT) (Berchtold et al., 2012). Thus, it has been proposed that
depletion of sphingolipids within the PM leads to Slm1/2 relocal-
ization and increased activation of Ypk1 as part of a homeostatic
feedback mechanism to maintain normal levels of sphingolipids.
The precise nature of the PM stress that results in Slm1/2 reloca-
tion following sphingolipid depletion remains ill defined.
Another important cellular process that has been linked to
TORC2/Ypk1/2 signaling is control of oxidative stress. In partic-
ular, we and others have observed that impaired TORC2/Ypk1/2
signaling results in increased expression of genes associated
with suppression of reactive oxygen species (ROS), specifically
genes regulated by the oxidative stress-responsive transcription
factor Yap1 (Mulet et al., 2006; Niles et al., 2012). ROS, which in-
cludes superoxide, hydrogen peroxide, and the hydroxyl radical,
are produced in cells as part of normal metabolism and haveell Reports 6, 541–552, February 13, 2014 ª2014 The Authors 541
Table 1. S. cerevisiae Strains Used in This Study
Strain Genotype Source
PLY062 W303a Nasmyth et al.,
1990
PLY521 W303a, ypk1::TRP this study
PLY1083 W303a, except ypk1::TRP1
ypk2::HIS3 + [pPL216]
Niles et al., 2012
PLY1098 W303a, except ypk1::TRP1
ypk2::HIS3 + [pPL220]
this study
PLY1134 W303a, except avo3-30-MYC:TRP1 Niles et al., 2012
PLY1360 W303a, except ypk2::HIS3 this study
INA17-4D MATa ura3 leu2 his2 trp1 ade1 Inagaki
et al., 1999
INA106-3B INA17-4D, except pkh1 D398G
pkh2::Leu2
Inagaki et al.,
1999
PLY1501 LHYa, except lac1::HIS lag1::TRP +
[pPL547]
this study
PLY1527 W303a, except ypk1::TRP1 ypk2::
HIS3 yap1::KanMX + [pPL220]
this study
PLY1528 W303a, except ypk1::TRP1 ypk2::
HIS3 rho0 + [pPL220]
this study
PLY1529 W303a, except ypk1::TRP1 ypk2::
HIS3 tpk3::KanMx + [pPL220]
this study
PLY1530 W303a, except ypk1::TRP1 ypk2::
HIS3 tpk3::KanMx rho0 + [pPL251]
this study
PLY1533 W303a, except ypk1::TRP1 ypk2::
HIS3 fpk1::KanMx + [pPL220]
this study
PLY1534 W303a, except ypk1::TRP1 ypk2::
HIS3 dnf3::markerless dnf2::NAT
dnf1::KanMx + [pPL220]
this study
PLY1535 W303a, except ypk1::TRP1
ypk2::HIS3 fpk1::NAT tpk3::
KanMx + [pPL251]
this study
PLY1536 W303a, except ypk1::TRP1
ypk2::HIS3 fpk1::KanMx rho0+
[pPL220]
this study
PLY1537 W303a, except ypk1::TRP1 ypk2::
HIS3 yap1::KanMx fpk1::NAT +
[pPL220]
this study
PLY1551 W303a, except fpk1::KanMx this study
PLY1555 W303a, except PIL1-mCherry:
KanMx + [pPL580]
this study
PLY1556 W303a, except ypk1::TRP1
ypk2::HIS3 lcb4::KanMx +
[pPL220]
this study
PLY1558 W303a, except ypk1::TRP1
ypk2::HIS3 fpk1::KanMx
lcb4::markerless + [pPL220]
this studymany beneficial roles, including signal transduction. Unregulated
ROS can result in cellular damage, however, including oxidation
of proteins, lipids, andDNA (Farrugia and Balzan, 2012). As such,
ROS are associated with many diseases, including neurodegen-
erative diseases like Alzheimer’s and Parkinson’s, cardiovas-
cular disease, cancer, as well as aging (Finkel, 2005). ROS are
produced from many sources in both mammalian and yeast542 Cell Reports 6, 541–552, February 13, 2014 ª2014 The Authorscells, with amajor source being themitochondrial electron trans-
port chain (Fang and Beattie, 2003). ROS are also produced from
nonmitochondrial sources, due to endoplasmic reticulum stress
(Haynes et al., 2004), and by exposure to heavy metals and other
environmental factors (Halliwell and Cross, 1994). More recently,
ROS has been shown to accumulate following defects in vacu-
olar acidification as well as decreased levels of sphingolipids
(Kajiwara et al., 2012; Milgrom et al., 2007).
Here, we report that impaired TORC2/Ypk1 signaling indeed
results in increased ROS that are produced by two distinct sour-
ces. One source is due to improper mitochondrial respiration
that we show is coupled to increased Protein kinase A (PKA) ac-
tivity and a subsequent repression of mitochondrial membrane
potential. The second source of ROS is due to defects in vacu-
olar acidification, which is caused by increased activity of the
amino phospholipid flippase kinase Fpk1 as well as decreased
levels of sphingolipids. Remarkably, we find that ROS associ-
ated with decreased sphingolipids is specifically responsible
for promoting changes in the localization of Slm1 at the PM
and for TORC2-dependent stimulation of Ypk1 phosphorylation.
Moreover, we demonstrate that ROS accumulation contributes
to decreased growth and survival within Ypk1-deficient cells.
Together, these results reveal a complex network regulated by
TORC2/Ypk1 signaling to sense and regulate ROS in cells to
maintain sphingolipid levels as well as cell viability.
RESULTS
TORC2/Ypk1 Signaling Modulates Intracellular ROS
TORC2/Ypk1/2 signaling negatively regulates the transcription
of genes controlled by the oxidative stress transcription factor
Yap1 (Mulet et al., 2006; Niles et al., 2012). Given the conse-
quences of oxidative damage that result from increased ROS,
we sought to test whether TORC2/Ypk1/2 signaling regulates
ROS accumulation. Toward this end, we examined the effect
of rapidly and specifically inhibiting Ypk1 by utilizing a plasmid-
expressed ATP-analog-sensitive allele of Ypk1 (Ypk1-AS) in a
strain deleted for endogenous YPK1 and YPK2 (Niles et al.,
2012; Tables 1 and 2). Indirect in vivo levels of ROS were quan-
tified as the percentage of growing cells that labeled with the
fluorescent ROS indicator dye H2DCFDA (DCF) (Lee et al.,
2011). To first confirm the reactivity of DCF to ROS under our
experimental conditions, we treated cells with H2O2, which
resulted in positive labeling of 100% of cells (Figure 1A).
We next treated Ypk1-AS cells with the inhibitor 2,3-DMB-PP1
for 1 hr, which resulted in a 4-fold increase in ROS compared to
addition of 2,3-DMB-PP1 to inhibitor-insensitive Ypk1-WT cells
(54% versus 12% DCF-positive cells) (Figure 1A). Consistent
with this difference being related to ROS, we observed a further
increase in DCF-positive cells (68%) when Ypk1-AS cells were
deleted for YAP1 (Figure 1A), because yap1D cells are known
to be deficient in removing ROS (Kuge et al., 1997). Moreover,
treating Ypk1-AS cells with N-acetyl cysteine (NAC), a ROS
scavenger, resulted in a partial reduction in ROS (30%DCF-pos-
itive cells) (Figure 1A). Because NAC is a specific scavenger of
free hydroxyl radicals (Brennan and Schiestl, 1997), the incom-
plete rescue we observed is likely due to additional forms of
radicals being produced in Ypk1-AS cells.
Table 2. Plasmids Used in This Study
Plasmid Parent Vector Insert/ORF Source
pRS315 Sikorski and Heiter,
1989
pRS316 Sikorski and Heiter,
1989
pRS425 Sikorski and Heiter,
1989
pPL187 Niles et al., 2012
pPL420 Niles et al., 2012
pPL215 pPL187 YPK1 Niles et al., 2012
pPL216 pRS316 YPK1 this study
pPL220 pRS316 YPK1L424G this study
pPL240 pPL187 YPK1D242A Niles et al., 2012
pPL251 pRS315 YPK1L424G Niles et al., 2012
pPL433 pPL420 YPK1 Niles et al., 2012
pPL419 pPL420 YPK1S644A/T662A this study
pPL530 pPL420 YPK1T504A this study
pPL547 pRS315 pTet-LAG1 this study
pPL580 p416Met25 SLM1-GFP this study
pPL582 pPL187 PDE2 this study
pPL585 pRS425 prCUP-6xMYC-
cki12-200 S125/130A
this studyThe low levels of ROS in Ypk1-WT cells (ypk1Dypk2D +
pYpk1-WT), which lack endogenous Ypk2 activity, suggested
Ypk2 does not contribute significantly to suppression of ROS.
We tested this directly by using single-gene deletions, where
we observed that ypk1D but not ypk2D cells have increased
ROS (Figure 1B). Because ROS is known to inhibit growth,
increased ROS may in part explain the slow growth phenotype
associated with ypk1D but not ypk2D cells (Chen et al., 1993)
(see below).
For Ypk1 to be activated, it must be first phosphorylated by
TORC2, which allows for subsequent phosphorylation by
Pkh1/2 (Casamayor et al., 1999; Niles et al., 2012). To test the
role of TORC2 and Pkh1/2 in Ypk1-dependent regulation of
ROS, we utilized temperature-sensitive pkh1/2-ts (pkh1D398G
pkh2D) and torc2-ts (avo3-30) alleles (Aronova et al., 2008; Ina-
gaki et al., 1999) to reduce the activity of Pkh1/2 and TORC2,
respectively. After shifting pkh1/2-ts cells to 37C, we found
that ROS increased significantly (53% DCF-positive cells). We
also observed elevated ROS in torc2-ts cells grown at both
permissive (25C) and nonpermissive (30C) temperatures (Fig-
ure 1C). Increased ROS at 25C is consistent with previous find-
ings that TORC2 activity is compromised in this mutant even at
the permissive temperature (Aronova et al., 2008; Niles et al.,
2012). We demonstrated further that increased ROS in torc2-ts
cells was specific to Ypk1 signaling, because expression of a
constitutively active allele of Ypk1 (Ypk1D242A) (Niles et al.,
2012), which bypasses the need for TORC2-dependent phos-
phorylation, reduced nearly all ROS in torc2-ts cells grown at
30C (Figure 1C). In addition, we transformed Ypk1-AS cells
with plasmids that expressed either WT Ypk1 or versions of
Ypk1 that carried mutations at the Pkh1/2 (Ypk1T504A) or theCTORC2 phosphorylation sites (Ypk1S644A/T662A) (Niles et al.,
2012). We observed that expression of WT Ypk1 suppressed
elevated ROS in Ypk1-AS cells, but not the Ypk1 phosphoryla-
tion-site mutants, despite the fact that all forms produced an
equal level of Ypk1 protein (Figure 1D). From these results, we
concluded that Ypk1 must be phosphorylated and activated by
both TORC2 and Pkh1/2 to prevent elevated ROS.
Because cells with increased ROS are more sensitive to treat-
ment with H2O2 (Lee et al., 2011), we examined the sensitivity of
Ypk1-AS cells to H2O2. We plated Ypk1-AS cells onto solid agar
plates containing sublethal concentrations of inhibitor, either in
the presence or absence of 0.5 mM H2O2, where Ypk1-WT cells
grew similarly on inhibitor-containing plates with or without H2O2
(Figure 1C). By contrast, growth of Ypk1-AS cells was reduced
significantly in the presence of H2O2 (Figure 1C). Moreover, dele-
tion of YAP1 from Ypk1-AS cells completely inhibited their
growth in the presence of analog and H2O2 (Figure 1D). Taken
together, our data demonstrate that TORC2/Ypk1 signaling is
essential for suppression of ROS.
TPK3-Dependent Mitochondrial Respiration Is a Source
for ROS in Ypk1-AS Cells
Because mitochondria are a known producer of free radicals
within cells, we examined the potential contribution of mitochon-
dria as a source of ROS in Ypk1-deficient cells. To do this, we
monitored ROS in Ypk1-AS cells that were made respiratory
deficient by loss of mitochondrial DNA (termed Ypk1-AS rho0
cells). We observed that ROS in Ypk1-AS rho0 cells were
reduced significantly compared to Ypk1-AS cells (26% versus
54% DCF-positive cells), suggesting Ypk1 signaling influences
mitochondrial respiratory activity (Figure 2A). To directly
examine the role of mitochondrial respiration on ROS, we treated
Ypk1-AS cells with 30 mM myxothiazol, a respiratory inhibitor
that blocks Complex III of the electron transport chain (Machida
et al., 1998), where a similar decrease in ROSwas observed (Fig-
ure 2A). As increased ROS from mitochondria often correlates
with defects in mitochondrial membrane potential (MMP), we
measured MMP in Ypk1-AS cells using the fluorescent dye
DiOC6 (Graef and Nunnari, 2011). Indeed, we observed that
inhibition of Ypk1 resulted in a 46% decrease in MMP, relative
to Ypk1-WT cells (Figure 2B). These results demonstrate a link
between TORC2/Ypk1 signaling and mitochondrial activity and
identify mitochondria as a source for ROS in Ypk1-AS cells.
ROS produced by mitochondria has been shown to increase
following inappropriate activation of Tpk3, one of three PKA cat-
alytic subunits (Leadsham and Gourlay, 2010). To test whether
mitochondrial ROS in Ypk1-AS cells was influenced by this
kinase, we examined ROS in Ypk1-AS cells following deletion
of TPK3. Indeed, we observed that ROS was reduced signifi-
cantly in Ypk1-AS tpk3D cells compared to Ypk1-AS cells (Fig-
ure 2A). Moreover, we observed very similar levels of ROS in
Ypk1-AS tpk3D and Ypk1-AS tpk3D rho0 cells (34% versus
31% DCF-positive cells), as would be expected if Tpk3 contrib-
utes to ROS produced bymitochondria (Figure 2A). In agreement
with these findings, we observed that deletion of TPK3 from
Ypk1-AS cells restored MMP (Figure 2B).
An important prediction from the above results was that Tpk3-
dependent PKA activity would be elevated in Ypk1-AS cells. Weell Reports 6, 541–552, February 13, 2014 ª2014 The Authors 543
Figure 1. TORC2/Ypk1 Signaling Regulates
ROS
(A) Ypk1-WT (PLY1083), Ypk1-AS (PLY1098), and
Ypk1-AS yap1D (PLY1527) were grown in SCD-
Ura media, either with or without 20 mM NAC and
then treated for 1 hr with 0.5 mM 2,3-DMB-PPI or
with 1 mM H2O2. All strains were incubated with
10 mM 2,7-dichlorofluorescin diacetate (DCF) for
the last 30 min prior to imaging by fluorescence
microscopy. Quantification represents percent-
age of 200–300 cells labeled with DCF, from at
least three experiments, with average presented
with means ± SEM.
(B) WT (PLY062), ypk1D (PLY521), and ypk2D
(PLY1360) cells were grown in SCD media, and
ROS was determined and quantified as in (A).
(C) WT (INA17-4D), pkh1/2-ts (INA106-3B), torc2-
ts (PLY1134), and PLY1134 transformed with
Ypk1D242A (pPL240) were grown overnight at 25C
and then shifted to 37C or 30C as noted for 1 hr.
ROS was determined and quantified as in (A).
(D) Ypk1-AS cells were transformedwith Ypk1-WT
(pPL433), Ypk1T504A (pPL530), or Ypk1S644A/T662A
(pPL491). Cells were grown in SCD-Ura/-Leu
media, and ROS was determined and quantified
as in (A). Protein extracts were prepared and
resolved by SDS/PAGE and immunoblotted with
a-HA antibody.
(E) Ypk1-WT, Ypk1-AS, and Ypk1-AS yap1D
(PLY1527) were grown on SCD-Ura plates con-
taining 0.5 mM 2,3-DMB-PPI with and without
0.5 mM H2O2 for approximately 2 days.therefore examined PKA activity in vivo using a PKA substrate
reporter plasmid, which encodes the first 200 amino acids of
the protein Cki1, which possesses two known PKA phosphoryla-
tion sites (Deminoff et al., 2006). Phosphorylation by PKA results
in a slower mobility species on SDS-PAGE gels, as detected by
western blot (referred to as Cki1-P). We observed an approxi-
mate 2-fold increase in the Cki1-P/Cki1 ratio in Ypk1-AS
compared to Ypk1-WT cells, thus confirming that PKA activity
was increased following Ypk1 inhibition (Figure 2C). This in-
crease was similar to treating cells with rapamycin, an inhibitor
of TORC1, which is known to increase PKA activity (Deminoff
et al., 2006). Importantly, we observed that deletion of TPK3
from Ypk1-AS cells reduced significantly Cki1 phosphorylation,
indicating Tpk3 is indeed primarily responsible for increased
PKA activity in Ypk1-AS cells (Figure 2C). Together from these
results, we conclude that Ypk1 and PKA interact functionally to
regulate mitochondrial ROS accumulation.
PKA activity is regulated positively by cAMP, where higher
levels of this molecule result in greater PKA activation. PDE2
encodes the phosphodiesterase that catalyzes the break-
down of cAMP (Leadsham and Gourlay, 2010). Interestingly,
we observed that PDE2 mRNA levels declined significantly in
Ypk1-AS cells, suggesting elevated PKA activity and a concom-
itant increase in ROS may result from decreased PDE2 expres-544 Cell Reports 6, 541–552, February 13, 2014 ª2014 The Authorssion (Niles et al., 2012) (Figure 2D). We
tested this directly by overexpressing
PDE2 in Ypk1-AS cells, where a signifi-cant reduction in ROS was observed (Figure 2D). Because we
observed similar levels of ROS in both Ypk1-AS tpk3D as well
as Ypk1-AS tpk3D cells overexpressing PDE2, these data sug-
gest that Pde2 specifically regulates Tpk3-dependent mitochon-
drial ROS production in Ypk1-AS cells.
Regulation of Vacuolar Acidification and ROS by the
Fpk1 Kinase
Because inhibition of mitochondrial respiration did not eliminate
completely ROS from Ypk1-deficient cells, we examined other
known targets of TORC2/Ypk1 signaling to identify additional
components that might contribute to ROS accumulation. One
recently identified target is the phospholipid flippase kinase
Fpk1, where direct phosphorylation by Ypk1 inhibits its activity
(Roelants et al., 2010). To test whether overactive Fpk1 plays a
role in ROS accumulation following inhibition of Ypk1, we
deleted FPK1 from Ypk1-AS cells and measured ROS. Indeed,
we observed that ROS dropped significantly in Ypk1-AS fpk1D
cells compared to Ypk1-AS cells (23% versus 54%DCF-positive
cells) (Figure 3A). Deletion of three of the five known flippase
genes (DNF1, DNF2, and DNF3) also resulted in a significant
reduction in ROS in Ypk1-AS cells, indicating that Fpk1-depen-
dent ROS was due primarily to its role in flippase activation
(Figure 3A).
Figure 2. PKA-Dependent Mitochondrial
ROS Production following Ypk1 Inhibition
(A) Ypk1-WT (PLY1083), Ypk1-AS (PLY1098),
Ypk1-AS rho0 (PLY1528), Ypk1-AS tpk3D
(PLY1529), and Ypk1-AS tpk3D rho0 (PLY1530)
were grown in SCD-Uramedia and then treated for
1 hr with 0.5 mM 2,3-DMB-PPI or with 30 mM
myxothiazol (myxo) for 70 min (including a 10 min
pretreatment) where noted. ROS was determined
and quantified as in Figure 1A.
(B) Ypk1-WT, Ypk1-AS, and Ypk1-AS tpk3D were
grown in SCD-Ura media and then treated for 1 hr
with 0.5 mM 2,3-DMB-PPI or with 50 mMCCCP. All
strains were incubated with 20 mM 3,30-dihex-
yloxacarbocyanine iodine (DiOC6) for the last 5min
prior to imaging by fluorescence microscopy.
Quantification represents pixel intensities from
several mitochondrial tubules from at least five
different cells.
(C) Ypk1-WT, Ypk1-AS, and Ypk1-AS tpk3D cells
transformed with pPL585 (Cki1) were grown in
SCD-Ura/-Leu media and then treated for 1 hr
with 0.5 mM 2,3-DMB-PPI or 30 min with 200 nM
rapamycin (Rap). Protein extracts were prepared
and resolved by SDS/PAGE and immunoblotted
with a-Myc antibody. Quantification describes the
ratio of Cki-P/Cki1 relative to Ypk1-WT for three
separate experiments.
(D) PDE2 transcript levels were compared
between Ypk1-AS and Ypk1-WT that had been
treated with 0.5 mM 2,3-DMB-PPI for the indicated
times (data from Niles et al., 2012).
(E) Ypk1-WT, Ypk1-AS, and Ypk1-AS and Ypk1-
AS tpk3D cells both transformed with pPL582
(PDE2) were grown in SCD-Ura/-Leu media
and then treated for 1 hr with 0.5 mM 2,3-DMB-
PPI. ROS was determined and quantified as in
Figure 1A.
Averages presented with means ± SEM.Because a similar reduction in ROS was observed when
Ypk1-deficient cells were either made respiratory incompetent
or deleted for FPK1 (compare Figures 2A and 3A), this raised
the question whether mitochondria and Fpk1 act within the
same pathway or in different pathways to regulate ROS.
Accordingly, we constructed a respiratory-deficient Ypk1-AS
fpk1D rho0 strain and measured ROS, which, remarkably,
exhibited levels of ROS that were very similar to Ypk1-WT cells
(Figure 3A). This result demonstrated that the ROS from over-
active Fpk1 was from a source different from mitochondrial
respiration and that both sources account for most, if not all,
of ROS observed in Ypk1-deficient cells. Importantly, WT
levels of ROS were also observed in Ypk1-AS fpk1D tpk3D
cells, consistent with our conclusion that Tpk3 and mitochon-Cell Reports 6, 541–552,dria function within the same pathway
to modulate ROS (Figure 3A).
Results of recent studies have demon-
strated that both phospholipid flippase
activity and oxidative stress are linked
to maintenance of vacuolar acidification
(Brett et al., 2011; Thorpe et al., 2004),suggesting loss of vacuolar acidification might contribute to
Fpk1-dependent ROS in Ypk1-deficient cells. To test this possi-
bility, we used the pH-reactive dye 5(6)-carboxyfluorescein
diacetate (5(6)-CFDA) (Preston et al., 1989) to examine whether
vacuole acidification was perturbed in Ypk1-AS cells. In Ypk1-
WT cells, 5(6)-CFDA labeling was restricted to the vacuole in
most cells, indicating normal vacuolar acidification (Figure 3A).
By contrast, in Ypk1-AS cells, 5(6)-CFDA labeling was either
greatly reduced or completely absent from vacuoles and instead
there was a concomitant increase in cytoplasmic labeling,
indicative of cytoplasmic acidification (Preston et al., 1989) (Fig-
ure 3B). This change was not related to mitochondrial respira-
tion, because a majority of Ypk1-AS rho0 cells also displayed
similar perturbations in vacuolar labeling (Figure 3B). ByFebruary 13, 2014 ª2014 The Authors 545
Figure 3. Overactive Fpk1 Results in Defects in Vacuolar Acidifica-
tion and ROS
(A) Ypk1-WT (PLY1083), Ypk1-AS (PLY1098), Ypk1-AS fpk1D (PLY1533),
Ypk1-AS dnf1Ddnf2Ddnf3D (PLY1534), Ypk1-AS fpk1D rho0 (PLY1536), and
Ypk1-AS fpk1Dtpk3D (PLY1535) were grown in SCD-Ura media and then
treated for 1 hr with 0.5 mM2,3-DMB-PPI. ROSwas determined and quantified
as in Figure 1A.
(B) Ypk1-WT, Ypk1-AS, Ypk1-AS fpk1D, and Ypk1-AS rho0 (PLY1528) were
grown in either SCD-Ura or SCD-Ura + 50 mM MES (pH 6.2), treated with
0.5 mM 2,3-DMB-PPI for 1 hr, and incubated for the last 30 min with 5 mM 5(6)-
Carboxyfluorescein diacetate (5[6]-CFDA). Quantification corresponds to the
percentage of labeled cells with cytoplasmic labeling, including cells with both
vacuolar and extravacuolar labeling, for three separate experiments. Scale
bar, 5 mm.
(C) Ypk1-WT, Ypk1-AS, Ypk1-AS rho0, Ypk1-AS fpk1D, and Ypk1-AS fpk1D
rho0 were grown in either SCD-Ura or SCD-Ura + 50 mM MES (pH 6.2) and
treated with 0.5 mM2,3-DMB-PPI for 1 hr. ROSwas determined and quantified
as in Figure 1A.
Averages presented with means ± SEM.
546 Cell Reports 6, 541–552, February 13, 2014 ª2014 The Authorscontrast, deletion of FPK1 from Ypk1-AS cells largely rescued
these defects, demonstrating that overactive Fpk1 results in
defects in vacuolar structure and/or function to cause changes
in acidification. Consistent with these findings, we observed
that we could neutralize a significant portion of the intracellular
acidification defects as well as elevated ROS in Ypk1-AS and
Ypk1-AS rho0 cells but observed no change in Ypk1-AS fpk1D
cells, by supplementing the growth media with the buffer MES
(pH 6.2) (Figures 3B and 3C). Together, these results support
the conclusion that intracellular acidification in Ypk1-AS cells
was caused by overactive Fpk1 and results in a unique source
of ROS that is independent from mitochondria.
Regulation of Vacuolar Acidification and ROS by
Sphingolipids
Sphingolipids have been shown recently to regulate both ROS
(Kajiwara et al., 2012) as well as vacuolar morphology and func-
tion (Chung et al., 2003; Faergeman et al., 2004). We therefore
hypothesized that decreased levels of sphingolipids may act in
concert with overactive Fpk1 to promote vacuolar acidification
defects and ROS in Ypk1-AS cells. Accordingly, we first tested
whether sphingolipid levels were altered in Ypk1-AS cells, by
using LC-MS/MS to measure levels of the major species of
ceramide in yeast, C26-PHS, where a significant decrease was
observed relative to Ypk1-WT cells (Figure 4A). We also exam-
ined levels of precursors to ceramides, the LCBs dihydros-
phingosine (DHS) and phytosphingosine (PHS), as well as their
phosphorylated forms (DHS-P and PHS-P). We observed that
Ypk1-AS cells possessed a significant reduction in PHS and
DHS and a commensurate increase in PHS-P and DHS-P (Fig-
ures 4B and 4C). These changes in ceramides, LCBs, and LCBPs
were remarkably similar to what we observed previously within
torc2-ts cells (Aronova et al., 2008). Importantly, a reduction in
ceramides is consistent with the hypothesis that reduced levels
of sphingolipids contribute to the accumulation of ROS in Ypk1-
AS cells.
To test directly if sphingolipid levels affect ROS in Ypk1-AS
cells, we first utilized an approach that we used previously to in-
crease sphingolipid levels in torc2-ts cells (Aronova et al., 2008).
Specifically, addition of PHS to torc2-ts cells, which also carry a
Figure 4. Regulation of Vacuolar Acidification and ROS by Sphingolipids
(A–C) Ypk1-WT (PLY1083) and Ypk1-AS (PLY1098) cells were grown in SCD-uracil and treated with 0.5 mM 2,3-DMB-PPI for 1 hr. Lipids were extracted, and
levels were analyzed by mass spectroscopy.
(D) Ypk1-WT, Ypk1-AS, Ypk1-AS lcb4D (PLY1556), Ypk1-AS fpk1D (PLY1533), and Ypk1-AS fpk1D lcb4D (PLY1558) cells were grown in SCD-uracil, with 4 mM
PHS where noted, and treated with 0.5 mM 2,3-DMB-PPI for 1 hr. ROS was determined and quantified as in Figure 1A.
(E) Ypk1-WT, Ypk1-AS, and Ypk1-AS lcb4D were grown in SCD-Ura, with 4 mM PHS where noted, and treated as in Figure 3B.
(F) WT (PLY062) and fpk1D (PLY1551) were grown in either SCD or SCD + 50 mMMES (pH 6.2) and treated with 1.25 mMmyriocin (Myr) for 2 hr. 5 mM 5(6)-CFDA
was added for the last 30 min. Quantification as in Figure 3B.
(G) Same as in (F), except ROS was determined and quantified as in Figure 1A.
(legend continued on next page)
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deletion for LCB4, the major LCB kinase, increased synthesis of
ceramides to a level that was sufficient to restore growth and
viability (Aronova et al., 2008). Here, we observed that treating
Ypk1-AS lcb4D cells with PHS significantly reduced ROS (29%
versus 54% DCF positive cells), indicating sphingolipids are
indeed involved in Ypk1-dependent regulation of ROS (Fig-
ure 4D). Moreover, we observed that levels of ROS were similar
in Ypk1-AS fpk1D cells, Ypk1-AS lcb4D cells treated with PHS,
and in Ypk1-AS fpk1Dlcb4D cells treated with PHS, suggesting
that sphingolipids and Fpk1 regulate ROS within the same
pathway (Figure 4D). To test whether sphingolipid depletion
affected ROS due to defects in vacuolar acidification, we treated
Ypk1-AS lcb4D cells with PHS and monitored acidification with
5(6)-CFDA. We found that, similar to deletion of Fpk1, addition
of PHS to Ypk1-AS lcb4D cells rescued the vacuolar acidification
defect in Ypk1-AS cells (Figure 4E). Thus, Fpk1 and sphin-
golipids both regulate ROS through maintenance of vacuolar
acidification.
We next took a second approach to examine further the
connection between Fpk1 and sphingolipids, by treating WT
and fpk1D cells with the sphingolipid biosynthesis inhibitor
drug myriocin and then measured vacuolar acidification. We
observed that, like inhibition of Ypk1, treating WT cells with myr-
iocin resulted in decreased vacuolar and increased cytoplasmic
acidification, both of which could be rectified by supplementing
myriocin-treated media with MES (pH 6.2) (Figure 4F). Impor-
tantly, deletion of FPK1 also rescued these myriocin-induced
acidification phenotypes (Figure 4F), confirming a role for Fpk1
in sphingolipid-dependent changes in vacuolar acidification.
Moreover, these observed acidification defects correlated with
changes in ROS, in that treating cells with myriocin caused a
significant increase in ROS that could be reversed either by the
addition of MES or by deletion of FPK1 (Figure 4G). To more
precisely determine the sphingolipid species that was required
to regulate vacuolar acidification, we inhibited sphingolipid
biosynthesis at two additional downstream steps, formation of
ceramides and formation of the complex sphingolipid species
inositol-phosphoceramide (IPC) (Figures 4H and 4I). We
observed that inhibition of both steps resulted in increased
ROS in a manner that could be prevented by addition of the
ROS scavenger NAC, demonstrating that biosynthesis of IPC
at least is necessary to prevent ROS (Figures 4H and 4I).
Sphingolipid-Mediated ROS Activates TORC2/Ypk1
Signaling
A link between sphingolipids and TORC2 phosphorylation of
Ypk1 has been previously demonstrated; however, the molecu-
lar basis for this regulation remains incompletely characterized
(Berchtold et al., 2012; Roelants et al., 2011). Given our results
above, we wanted to test whether increased Ypk1 phosphoryla-
tion following sphingolipid depletion was dependent on ROS.
Thus, we pretreated WT cells with NAC prior to treatment with(H) WT cells grown in SCDmedia with or without 20mMNAC (pH 8.0) were treated
1 hr. lag1Dlac1D + pTet-LAG1 (PLY1501) cells were grown in SCDwith or without
and retreated two times). ROS was determined and quantified as in Figure 1A.
(I) Simplified schematic diagram of the sphingolipid biosynthetic pathway in S. c
Averages presented with means ± SEM.
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Ypk1 at the hydrophobic motif phosphorylation site (serine
662) (Niles et al., 2012). We observed that myriocin-induced
hyperphosphorylation of Ypk1 was significantly attenuated by
addition of NAC (Figure 5A). Similar results were observed
when we interrupted sphingolipid biosynthesis at the formation
of ceramides and IPC, consistent with increased phosphoryla-
tion of Ypk1 following sphingolipid depletion due specifically to
increased ROS (Figure 5A).
Because increased phosphorylation of Ypk1 following treat-
ment with myriocin requires the relocalization of Slm1 from eiso-
somes to the MCT (Berchtold et al., 2012), we examined whether
this step was ROS dependent as well using Slm1-GFP and
fluorescence microscopy. As described previously (Berchtold
et al., 2012), in untreated cells a significant proportion of Slm1-
GFP is localized to punctate structures marked by the eisosome
component Pil1-mCherry and is displaced from eisosomes
following myriocin treatment, a result that we confirmed (Figures
5B and 5C). Remarkably, we observed that this relocalization
was prevented completely by preincubation with NAC (Figures
5B and 5C). We concluded from these findings that ROS is the
critical signal within a feedback loop that links sphingo-
lipid depletion to phosphorylation of Ypk1 by TORC2, which acts
both to increase sphingolipid biosynthesis aswell as reduceROS.
Regulation of ROS by Ypk1 Is Essential for Growth and
Survival
One important function of homeostatic feedback mechanisms is
to ensure survival of cells under stress. Therefore, we asked
whether the essential function of Ypk1 is related to its suppres-
sion of ROS accumulation. Accordingly, we examined the
growth of strains on solid agar plates containing 1 mM 2,3-
DMB-PP1, which was sufficient to prevent growth of Ypk1-AS
but not Ypk1-WT cells (Figure 6A). We observed that deletion
of FPK1 resulted in partial rescue of growth for Ypk1-AS cells
and that there was additional improvement by eliminating mito-
chondrial respiration, because Ypk1-AS fpk1D rho0 cells grew
almost as well as Ypk1-WT cells (Figure 6A). Because the rescue
of growth in Ypk1-AS fpk1D cells required Yap1, we concluded
that this rescue was due specifically to a reduction in ROS (Fig-
ure 6B). In addition, whereas loss of mitochondrial respiration
alone was insufficient to rescue growth, we observed that
neutralizing cytoplasmic acidification and reducing ROS further
by adding MES to plates enabled Ypk1-AS rho0 cells to grow
nearly as well as Ypk1-WT cells (Figure 6C). We concluded
from these results that elevated ROS is a major cause of growth
inhibition in Ypk1-deficient cells.
As the accumulation of ROS also leads to a rapid decrease in
cell viability (Cabiscol et al., 2000), we hypothesized that growth
inhibition was due to an increase in ROS-mediated cell killing in
Ypk1-AS cells. To test this, we performed a short-term inhibition
of Ypk1-AS in liquid cell culture, followed by plating an equalwith either DMSO, 1.25 mMmyriocin (Myr), or 1.25 mMaureobasidin A (AbA) for
20mMNACwere treated with 30 mg/ml doxycycline for 2 days (cultures diluted
erevisiae, including steps modified by inhibitor drugs.
Figure 5. Increased ROS Activates TORC2 Phosphorylation of Ypk1
(A) WT (PLY062) and lag1Dlac1D + pTet-Lag1 (PLY1501) cells transformed
with pPL215 (Ypk1-HA) were grown as in SCD-Ura as in Figure 4H. Cells were
harvested and lysed, and the resulting protein extracts were resolved by SDS/
PAGE and immunoblotted with a-phospho-Ypk1 (T662), a-HA, and a-G6PDH
(as a loading control) antisera. Quantification is relative to untreated WT from
each strain, after normalizing to the a-HA signal.
(B) Pil1-mCherry-tagged W303 coexpressing Slm1-GFP (PLY1555) were
grown in SCD minus uracil media, with or without 20 mM NAC (pH 8.0),
overnight and then treated with DMSO or 1.25 mM Myriocin for 1 hr. Top
section images were collected by confocal microscopy. Inlays depict magni-
fied regions of Slm1 (left), Pil1 (middle), and overlay (right).
(C) Colocalization was determined using the Pearson coefficient (ImageJ
software).
Averages presented with means ± SEM.
Figure 6. ROS Prevention Is an Essential Function of TORC2/Ypk1
Signaling
(A) Ypk1-WT (PLY1083), Ypk1-AS (PLY1098), Ypk1-AS rho0 (PLY1528), Ypk1-
AS fpk1D (PLY1533), and Ypk1-AS fpk1D rho0 (PLY1536) were grown on SCD-
Ura plates with and without 1 mM 2,3-DMB-PPI for approximately 2 days.
(B) Ypk1-AS, Ypk1-AS fpk1D, and Ypk1-AS fpk1Dyap1D (PLY1537) were
grown on SCD-Ura plates with and without 1 mM 2,3-DMB-PPI for approxi-
mately 2 days.
(C) Ypk1-WT, Ypk1-AS, and Ypk1-AS rho0 were grown on SCD-Ura plates
containing 1 mM 2,3-DMB-PPI and with or without 50 mM MES (pH 6.2) for
approximately 2 days.
(D) WT (PLY062) were grown overnight in YPD. Equal numbers of cells were
serially diluted and plated on YPD control plate, or YPD plus 1 mMmyriocin, or
plus 1 mM myriocin and 20 mM NAC, and grown for approximately 2 days.
(E) Ypk1-WT, Ypk1-AS, Ypk1-AS rho0, Ypk1-AS fpk1D, and Ypk1-AS fpk1D
rho0 were grown in SCD-Ura and then treated with 5 mM 2,3-DMB-PPI for 5 hr,
and then equal number of cells were plated onto SCD-Ura plates without in-
hibitor and grown for approximately 2 days. Number of colonies were counted
and normalized to Ypk1-WT.
Averages presented with means ± SEM.number of cells onto solid agar plates without inhibitor and
counted the number of resulting colonies formed after 2 days.
Thus, although only 10% of Ypk1-AS cells survived, approxi-
mately 40%of Ypk1-AS fpk1D rho0 cells survived brief treatment
with inhibitor (Figure 6E). These differences were specific for
Ypk1 inhibition, because all four strains grew identically in the
absence of inhibitor. Taken together, we concluded that regula-
tion of ROS by TORC2/Ypk1 signaling is essential formaintaining
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Finally, previous studies have shown that a kinase dead
version of Fpk1 or deletion of DNF1/2/3 afforded greater resis-
tance to myriocin (Roelants et al., 2010). Based on our present
results, we hypothesized that elevated ROS is responsible for
growth inhibition following sphingolipid depletion. To test this,
we plated WT cells on YPD plates that contained either
myriocin or myriocin plus NAC and compared this to growth on
untreated plates. Thus, whereas no growth was observed on
plates containing myriocin, growth was restored on plates that
included NAC (Figure 6D). Thus, we conclude that ROS is a pri-
mary cause of cell death following sphingolipid depletion.
DISCUSSION
Our findings presented here demonstrate that TORC2/Ypk1
signaling plays a critical role in both modulating as well
as responding to intracellular levels of ROS. In particular, we
have shown that Ypk1 activity suppresses ROS that accumulate
through two distinct sources, one of which results from impaired
mitochondrial respiration and reduced mitochondrial membrane
potential, and a second source that is attributable to defects in
vacuolar acidification andaberrant acidificationof thecytoplasm.
Importantly, we find that intracellular levels of sphingolipids
contribute both to maintenance of vacuolar acidification as well
as suppression of ROS. Remarkably, the ROS that results from
sphingolipid depletion leads to hyperphosphorylation andactiva-
tion of Ypk1 by TORC2, wherein activated Ypk1 in turn functions
as a positive regulator of sphingolipid biosynthesis. Thus, our
findings reveal an important role for ROS as a signal to activate
TORC2/Ypk1 signaling, both to maintain appropriate levels of
sphingolipids as well as suppress the accumulation of ROS.
The identification of mitochondria as a source of ROS in Ypk1-
deficient cells reveals an unexpected link between TORC2/Ypk1
signaling and PKA-mediated regulation of mitochondrial activity,
specifically involving the Tpk3 catalytic subunit of PKA. Previous
studies have established complex regulatory relationships
between TORC1 and PKA, but so far little is known about how
TORC2 may interact functionally with PKA. Our results are
consistent with prior findings that Tpk3 is required for increased
mitochondria-derived ROS following activation of Ras, an up-
stream activator of PKA (Gourlay and Ayscough, 2006). In addi-
tion, overactive Tpk3 has been shown to repress the expression
of genes that encode components of the mitochondrial electron
transport chain, suggesting a possible mechanism by which
MMP is decreased and ROS is increased in Tpk3-activated cells
(Leadsham and Gourlay, 2010). Interestingly, our own DNA
microarray analyses identified many of these same target genes
as being downregulated in Ypk1-deficient cells (Niles et al.,
2012). Furthermore, here we have now identified Ypk1-mediated
repression of PDE2, which encodes the cAMP phosphodies-
terase that negatively regulates PKA activity, as a potential
mechanism by which Tpk3 activity is increased in Ypk1-deficient
cells. Potential factors that regulate PDE2 expression and/or
mRNA stability and that thus could be a target for TORC2/
Ypk1 regulation remain to be identified.
Our discovery that defects in vacuolar acidification represent
a second source of ROS in Ypk1-deficient cells emphasizes
emerging connections between vacuolar and mitochondrial550 Cell Reports 6, 541–552, February 13, 2014 ª2014 The Authorsfunction, including a recent study where changes in vacuolar
pH are linked to alterations in MMP and result in decreased
replicative lifespan in yeast (Hughes and Gottschling, 2012).
Moreover, because we demonstrate that maintenance of vacu-
olar pH is affected both by the phospholipid flippase Fpk1 as
well as sphingolipids, our data reveal that the proper content
as well as distribution of both types of lipids are likely to be
important for normal vacuolar acidification. Proper acidification
of the vacuole depends on the vacuolar proton gradient that is
generated by the vacuolar H+-ATPase (V-ATPase), where de-
fects in its activity have been linked to cytoplasmic acidification
and the generation of ROS (Milgrom et al., 2007). The yeast
V-ATPase consists of at least 14 different protein subunits that
assemble into two distinct complexes (V0 and V1), which then
form two different subpopulations of enzyme, one that is retained
with the Golgi/endosomal network and another that is trans-
ported to the vacuole (Manolson et al., 1994; Nishi and Forgac,
2002). Hyperactive Fpk1 within Ypk1-deficient cells could
feasibly disrupt any number of steps in V-ATPase assembly
and/or trafficking, given that phospholipid flippase regulation
is crucial for proper protein sorting within both endosomes as
well as the vacuole (Hua et al., 2002). Similarly, appropriate levels
of sphingolipids are also known to be important for generation of
a functional V1 domain (Chung et al., 2003). The precise func-
tional relationship between Fpk1 and sphingolipids, in particular,
with respect to maintenance of vacuolar acidification and their
links to TORC/Ypk1 signaling, remains to be determined.
Perhaps one of the most significant findings presented here is
that accumulation of ROS following sphingolipid depletion is
responsible for the changes in localization of Slm1 from eiso-
somes to the MCT, where TORC2-mediated phosphorylation
of Ypk1 occurs. Previously, it was suggested that loss of sphin-
golipids by treatment with myriocin results in deformation of the
PM, an effect that could be mimicked by mechanical membrane
‘‘stretching,’’ and that this induces a stress that presumably dis-
rupts interactions between eisosomes and Slm1 (Berchtold
et al., 2012). Based upon our data, we suggest that ROS gener-
ated by sphingolipid depletion may affect directly the associa-
tion of Slm1 with eisosomes. Eisosomes are composed of
dozens of proteins, including the core structural components
Pil1 and Lsp1 (Walther et al., 2006). Interestingly, myriocin treat-
ment is known to affect eisosome assembly as well as stability
(Luo et al., 2008). Thus, should any of these proteins be sensitive
to damage by ROS, this could explain in part changes in eiso-
some structure that perturb interactions with Slm1. Alternatively,
Slm1 possesses two membrane binding domains, an F-BAR
domain as well as a PH domain, both of which are required for
localization to eisosomes (Olivera-Couto et al., 2011). Thus,
damage to these membrane binding domains and/or oxidation
of their target lipids could result in the release of Slm1 from eiso-
somes, allowing for subsequent relocalization to the MCT.
Because unregulated ROS is associated with numerous dis-
eases, including neurodegenerative diseases like Alzheimer’s
and Parkinson’s, cardiovascular disease, cancer, as well as
aging (reviewed in Finkel, 2005), understanding the scope of
signaling pathways that are responsible for ROS accumulation
in eukaryotic cells remains of great importance. Therefore, our
findings are important as they reveal that the conserved
TORC2 signaling network plays an important role in the regula-
tion of ROS and, moreover, demonstrate that ROS can act as
an important signal for the activation of TORC2. We argue that
features of the regulation we have identified in yeast are likely
to be conserved in higher eukaryotes, given the extensive
conservation of TORC2 signaling. For example, the P4 ATPase
family of flippases, which are aberrantly hyperactivated in
Ypk1-deficient cells, has been associated with several different
disease states in mammals (Folmer et al., 2009). Furthermore,
recent studies in mammalian cells have shown that signaling
from mTORC2 to the downstream targets Akt and SGK1 is influ-
enced by ROS (Nayak et al., 2013). Because both ROS and
mTORC2 activity are often elevated in cancer cells (Masri
et al., 2007; Szatrowski and Nathan, 1991), an intriguing possibil-
ity is that ROS stimulates the activity of mTORC2, thus leading to
activation of prosurvival pathways in these cells. Because
mTORC2 inhibitors are developed for treatment of cancer, our
findings suggest that specifically targeting the ROS-related
stress-responsive functions of mTORC2 signaling could repre-
sent a novel avenue for therapeutic development.
EXPERIMENTAL PROCEDURES
Strains, Media, and Plasmids
Yeast strains and plasmids used in this study are listed in Tables 1 and 2.
Culture medium used was synthetic complete dextrose (SCD) (0.8% yeast
nitrogen base without amino acids [pH 5.5], 2% dextrose) supplemented
with amino acids as described previously (Sherman, 1991). All yeast transfor-
mations were conducted using a lithium acetate procedure (Geitz andWoods,
1998). Strains were made respiratory deficient (rho0) by treating with 25 mg/ml
ethidium bromide for 16 hr, as described in Fox et al. (1991). Construction of
deletion strains was performed as described previously (Dilova et al., 2004;
Gu¨ldener et al., 1996). Construction of expression plasmids was performed
by PCR amplification, with mutations introduced by PCR SOEing. pPL547
was made by inserting the Tet-repressible promoter from pCM184 (ATCC)
before Lag1 in pRS315 using the NotI and HindIII restriction sites. pPL585
was constructed by removing the entire cassette from pPHY2328 (Deminoff
et al., 2006) with the restriction enzymes XhoI and SacI, and ligating it into
pRS425.
Fluorescence Microscopy
DFC-DA, 5(6)CFDA, and DiOC6 imaging was performed using a Nikon E600
fluorescent microscope as described (Niles et al., 2012). Fluorescent protein
imaging was performed using the spinning disc module of a Marianas SDC
Real Time 3D Confocal-TIRF microscope (Intelligent Imaging Innovations, 3i)
as described (Niles et al., 2012). Image capture and processing was done
using SlideBook5 software (3i), and Photoshop (Adobe). Pearson coefficient
for colocalization determined using ImageJ software (NIH) as previously
described (French et al., 2008).
Western Blotting
Protein extracts were prepared using the NaOH cell lysis method (Dilova
et al., 2004) and loaded onto SDS-PAGE gels and transferred to nitrocellulose
membrane.Membranes were probed with a-phospho-Ypk1(T662) (Niles et al.,
2012), a-Myc (1:1000; Covance), a-HA (12CA5, 1:5000; Covance), and
a-G6PDH (1:100,000; Sigma-Aldrich) primary antibodies and visualized using
the appropriate secondary antibodies conjugated to IRDye (1:5000; LI-COR
Biosciences) on the Odyssey Infrared Imaging System (LI-COR Biosciences).
Images were quantified using ImageQuant software (GE Healthcare).
LC-MS/MS Analysis of LCBs, LCBPs, and Ceramides
Lipids were extracted and analyzed as described in Aronova et al. (2008),
using a Applied Biosystems Qtrap 4000 triple quadrupole mass spectrometerCcoupled to a Waters Acquity Ultra Performance LC system (UC Davis Metab-
olomics Core).
Statistical Analysis
Averages are presented with means ± SEM. p values were calculated using
Student’s t test.
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